am 251 has been researched along with Uveitis in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"This study aimed to investigate the effects of anandamide or arachidonylethanolamide (AEA), an endogenous cannabinoid receptor agonist, on intraocular inflammation in an endotoxin-induced uveitis (EIU) model in rabbits." | 7.77 | A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits. ( Altinsoy, A; Bagriacik, EU; Dileköz, E; Ercan, ZS; Ilhan, SÖ; Kul, O; Or, M; Sarioglu, Y; Seven, I; Tunccan, OG, 2011) |
"This study aimed to investigate the effects of anandamide or arachidonylethanolamide (AEA), an endogenous cannabinoid receptor agonist, on intraocular inflammation in an endotoxin-induced uveitis (EIU) model in rabbits." | 3.77 | A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits. ( Altinsoy, A; Bagriacik, EU; Dileköz, E; Ercan, ZS; Ilhan, SÖ; Kul, O; Or, M; Sarioglu, Y; Seven, I; Tunccan, OG, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altinsoy, A | 1 |
Dileköz, E | 1 |
Kul, O | 1 |
Ilhan, SÖ | 1 |
Tunccan, OG | 1 |
Seven, I | 1 |
Bagriacik, EU | 1 |
Sarioglu, Y | 1 |
Or, M | 1 |
Ercan, ZS | 1 |
1 other study available for am 251 and Uveitis
Article | Year |
---|---|
A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Disease Models, Animal; Drug Synergism; E | 2011 |